Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4H5F5
Term | Name | Level | Count |
---|---|---|---|
GO:0000959 | mitochondrial RNA metabolic process | 6 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1900864 | mitochondrial RNA modification | 6 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0003729 | mRNA binding | 5 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 175 | 177 | PF00675 | 0.375 |
CLV_NRD_NRD_1 | 19 | 21 | PF00675 | 0.378 |
CLV_NRD_NRD_1 | 375 | 377 | PF00675 | 0.289 |
CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.331 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.378 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.354 |
CLV_PCSK_KEX2_1 | 319 | 321 | PF00082 | 0.319 |
CLV_PCSK_KEX2_1 | 375 | 377 | PF00082 | 0.289 |
CLV_PCSK_PC1ET2_1 | 208 | 210 | PF00082 | 0.354 |
CLV_PCSK_PC1ET2_1 | 319 | 321 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.330 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 346 | 350 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 375 | 379 | PF00082 | 0.269 |
DEG_APCC_DBOX_1 | 374 | 382 | PF00400 | 0.270 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.411 |
DOC_CYCLIN_RxL_1 | 17 | 26 | PF00134 | 0.360 |
DOC_CYCLIN_RxL_1 | 372 | 380 | PF00134 | 0.435 |
DOC_CYCLIN_RxL_1 | 395 | 405 | PF00134 | 0.321 |
DOC_MAPK_gen_1 | 129 | 138 | PF00069 | 0.211 |
DOC_MAPK_gen_1 | 54 | 62 | PF00069 | 0.402 |
DOC_MAPK_gen_1 | 65 | 74 | PF00069 | 0.356 |
DOC_MAPK_gen_1 | 88 | 96 | PF00069 | 0.322 |
DOC_MAPK_MEF2A_6 | 65 | 74 | PF00069 | 0.346 |
DOC_PP1_RVXF_1 | 17 | 24 | PF00149 | 0.366 |
DOC_PP1_RVXF_1 | 296 | 303 | PF00149 | 0.196 |
DOC_PP1_RVXF_1 | 373 | 380 | PF00149 | 0.285 |
DOC_PP4_FxxP_1 | 407 | 410 | PF00568 | 0.370 |
DOC_PP4_FxxP_1 | 427 | 430 | PF00568 | 0.353 |
DOC_USP7_UBL2_3 | 198 | 202 | PF12436 | 0.358 |
DOC_USP7_UBL2_3 | 383 | 387 | PF12436 | 0.299 |
LIG_14-3-3_CanoR_1 | 132 | 137 | PF00244 | 0.316 |
LIG_14-3-3_CanoR_1 | 175 | 181 | PF00244 | 0.365 |
LIG_14-3-3_CanoR_1 | 183 | 187 | PF00244 | 0.349 |
LIG_14-3-3_CanoR_1 | 320 | 328 | PF00244 | 0.293 |
LIG_14-3-3_CanoR_1 | 376 | 382 | PF00244 | 0.297 |
LIG_14-3-3_CterR_2 | 438 | 442 | PF00244 | 0.408 |
LIG_APCC_ABBA_1 | 400 | 405 | PF00400 | 0.349 |
LIG_BIR_III_4 | 109 | 113 | PF00653 | 0.374 |
LIG_BRCT_BRCA1_1 | 206 | 210 | PF00533 | 0.338 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.368 |
LIG_FHA_1 | 345 | 351 | PF00498 | 0.335 |
LIG_FHA_2 | 183 | 189 | PF00498 | 0.350 |
LIG_LIR_Apic_2 | 405 | 410 | PF02991 | 0.356 |
LIG_LIR_Gen_1 | 269 | 278 | PF02991 | 0.373 |
LIG_LIR_Gen_1 | 279 | 289 | PF02991 | 0.287 |
LIG_LIR_Gen_1 | 417 | 427 | PF02991 | 0.476 |
LIG_LIR_Gen_1 | 67 | 77 | PF02991 | 0.490 |
LIG_LIR_Nem_3 | 128 | 134 | PF02991 | 0.290 |
LIG_LIR_Nem_3 | 241 | 247 | PF02991 | 0.376 |
LIG_LIR_Nem_3 | 269 | 273 | PF02991 | 0.317 |
LIG_LIR_Nem_3 | 279 | 284 | PF02991 | 0.242 |
LIG_LIR_Nem_3 | 315 | 321 | PF02991 | 0.320 |
LIG_LIR_Nem_3 | 330 | 335 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 417 | 423 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 67 | 72 | PF02991 | 0.386 |
LIG_NRBOX | 129 | 135 | PF00104 | 0.294 |
LIG_Pex14_2 | 344 | 348 | PF04695 | 0.455 |
LIG_Pex14_2 | 423 | 427 | PF04695 | 0.478 |
LIG_PTB_Apo_2 | 63 | 70 | PF02174 | 0.471 |
LIG_SH2_CRK | 240 | 244 | PF00017 | 0.311 |
LIG_SH2_STAP1 | 240 | 244 | PF00017 | 0.311 |
LIG_SH2_STAT3 | 164 | 167 | PF00017 | 0.243 |
LIG_SH2_STAT3 | 217 | 220 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 235 | 238 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.296 |
LIG_SH2_STAT5 | 364 | 367 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.344 |
LIG_SH3_3 | 383 | 389 | PF00018 | 0.353 |
LIG_SH3_3 | 419 | 425 | PF00018 | 0.489 |
LIG_SUMO_SIM_anti_2 | 36 | 41 | PF11976 | 0.321 |
LIG_SUMO_SIM_anti_2 | 71 | 76 | PF11976 | 0.323 |
LIG_SUMO_SIM_par_1 | 352 | 360 | PF11976 | 0.401 |
LIG_SUMO_SIM_par_1 | 75 | 80 | PF11976 | 0.326 |
LIG_TYR_ITIM | 238 | 243 | PF00017 | 0.328 |
LIG_UBA3_1 | 377 | 383 | PF00899 | 0.285 |
LIG_WRC_WIRS_1 | 267 | 272 | PF05994 | 0.493 |
LIG_WW_1 | 429 | 432 | PF00397 | 0.326 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.330 |
MOD_CK2_1 | 176 | 182 | PF00069 | 0.403 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.353 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.212 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.318 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.312 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.199 |
MOD_GSK3_1 | 320 | 327 | PF00069 | 0.265 |
MOD_GSK3_1 | 434 | 441 | PF00069 | 0.464 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.303 |
MOD_N-GLC_2 | 397 | 399 | PF02516 | 0.315 |
MOD_N-GLC_2 | 426 | 428 | PF02516 | 0.301 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.334 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.346 |
MOD_NEK2_1 | 302 | 307 | PF00069 | 0.411 |
MOD_NEK2_1 | 337 | 342 | PF00069 | 0.285 |
MOD_NEK2_1 | 344 | 349 | PF00069 | 0.318 |
MOD_NEK2_1 | 377 | 382 | PF00069 | 0.265 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.434 |
MOD_NEK2_1 | 434 | 439 | PF00069 | 0.357 |
MOD_NEK2_2 | 81 | 86 | PF00069 | 0.312 |
MOD_PKA_2 | 182 | 188 | PF00069 | 0.346 |
MOD_Plk_1 | 298 | 304 | PF00069 | 0.241 |
MOD_Plk_2-3 | 182 | 188 | PF00069 | 0.353 |
MOD_SUMO_for_1 | 312 | 315 | PF00179 | 0.355 |
MOD_SUMO_rev_2 | 197 | 207 | PF00179 | 0.347 |
MOD_SUMO_rev_2 | 294 | 300 | PF00179 | 0.455 |
TRG_DiLeu_BaEn_1 | 148 | 153 | PF01217 | 0.306 |
TRG_DiLeu_BaLyEn_6 | 129 | 134 | PF01217 | 0.219 |
TRG_DiLeu_BaLyEn_6 | 373 | 378 | PF01217 | 0.424 |
TRG_DiLeu_LyEn_5 | 188 | 193 | PF01217 | 0.296 |
TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.334 |
TRG_ENDOCYTIC_2 | 240 | 243 | PF00928 | 0.315 |
TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.359 |
TRG_ER_diArg_1 | 161 | 164 | PF00400 | 0.347 |
TRG_ER_diArg_1 | 19 | 21 | PF00400 | 0.378 |
TRG_ER_diArg_1 | 374 | 376 | PF00400 | 0.292 |
TRG_NES_CRM1_1 | 128 | 139 | PF08389 | 0.297 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6Z9 | Leptomonas seymouri | 24% | 92% |
A0A0N1HY66 | Leptomonas seymouri | 89% | 82% |
A0A0S4IS85 | Bodo saltans | 83% | 84% |
A0A1X0NEZ9 | Trypanosomatidae | 87% | 86% |
A0A1X0P8G7 | Trypanosomatidae | 25% | 91% |
A0A3S5H691 | Leishmania donovani | 97% | 100% |
A0A422NFX5 | Trypanosoma rangeli | 87% | 85% |
A0A422P283 | Trypanosoma rangeli | 26% | 92% |
A4HNQ2 | Leishmania braziliensis | 23% | 92% |
A4HTQ0 | Leishmania infantum | 97% | 100% |
C9ZPF4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 87% | 86% |
D0A2L1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 94% |
E9AMI7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
E9ASG1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 92% |
Q4QI52 | Leishmania major | 96% | 100% |
V5BEF0 | Trypanosoma cruzi | 87% | 85% |
V5BQI6 | Trypanosoma cruzi | 25% | 92% |